scPharmaceuticals Inc. (SCPH) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
scPharmaceuticals Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • scPharmaceuticals Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$295 M, a 24.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$295 M -$57.7 M -24.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$281 M -$54.8 M -24.2% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 -$268 M -$50.2 M -23.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$252 M -$44.8 M -21.6% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$238 M -$40.3 M -20.4% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$227 M -$36.8 M -19.4% Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$217 M -$34.9 M -19.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$207 M -$31.3 M -17.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$197 M -$28.7 M -17% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$190 M -$28 M -17.3% Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$182 M -$28.5 M -18.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$176 M -$31 M -21.4% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 -$169 M -$32.2 M -23.6% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 -$162 M -$32.2 M -24.9% Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$154 M -$35.2 M -29.7% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 -$145 M -$32.4 M -28.8% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 -$137 M -$31.4 M -29.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 -$129 M -$33 M -34.2% Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$119 M -$27.3 M -29.9% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$112 M -$26.8 M -31.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$105 M -$29.4 M -38.9% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$96.5 M -$29.4 M -43.9% Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$91.4 M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 -$85.6 M Jun 30, 2018 10-Q 2018-08-14
Q1 2018 -$75.7 M Mar 31, 2018 10-Q 2018-05-07
Q4 2017 -$67 M Dec 31, 2017 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.